These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 8120376)

  • 61. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes.
    Anderson P; Nagler-Anderson C; O'Brien C; Levine H; Watkins S; Slayter HS; Blue ML; Schlossman SF
    J Immunol; 1990 Jan; 144(2):574-82. PubMed ID: 2104899
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell.
    Tarkkanen J; Saksela E; Lanier LL
    J Immunol; 1986 Oct; 137(8):2428-33. PubMed ID: 3093576
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CD2 is functionally linked to the zeta-natural killer receptor complex.
    Vivier E; Morin PM; O'Brien C; Schlossman SF; Anderson P
    Eur J Immunol; 1991 Apr; 21(4):1077-80. PubMed ID: 1673433
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
    Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes.
    Sidorenko SP; Clark EA
    J Immunol; 1993 Nov; 151(9):4614-24. PubMed ID: 8409422
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cross-linking of the Fas/APO-1 antigen suppresses the CD3-mediated signal transduction events in human T lymphocytes.
    Kovacs B; Tsokos GC
    J Immunol; 1995 Dec; 155(12):5543-9. PubMed ID: 7499836
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells.
    Galandrini R; Galluzzo E; Albi N; Grossi CE; Velardi A
    J Immunol; 1994 Jul; 153(1):21-31. PubMed ID: 7515923
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells.
    Ware CF; Crowe PD; Grayson MH; Androlewicz MJ; Browning JL
    J Immunol; 1992 Dec; 149(12):3881-8. PubMed ID: 1281193
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns.
    Doherty DG; Norris S; Madrigal-Estebas L; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
    J Immunol; 1999 Aug; 163(4):2314-21. PubMed ID: 10438977
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells.
    Ortaldo JR; Winkler-Pickett R; Mason AT; Mason LH
    J Immunol; 1998 Feb; 160(3):1158-65. PubMed ID: 9570529
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing.
    Vivier E; Morin P; O'Brien C; Druker B; Schlossman SF; Anderson P
    J Immunol; 1991 Jan; 146(1):206-10. PubMed ID: 1701792
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Activation of natural killer cells via the Fc gamma RIII (CD16) requires initial tyrosine phosphorylation.
    Ståhls A; Heiskala M; Mustelin T; Andersson LC
    Eur J Immunol; 1992 Feb; 22(2):611-4. PubMed ID: 1371474
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro.
    Iho S; Yamamoto T; Takahashi T; Yamamoto S
    J Immunol; 1999 Oct; 163(7):3642-52. PubMed ID: 10490958
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of a 140-kDa activation antigen as a target structure for a series of human cloned natural killer cell lines.
    Hercend T; Schmidt R; Brennan A; Edson MA; Reinherz EL; Schlossman SF; Ritz J
    Eur J Immunol; 1984 Sep; 14(9):844-52. PubMed ID: 6479209
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor.
    Pérez-Villar JJ; Carretero M; Navarro F; Melero I; Rodríguez A; Bottino C; Moretta A; López-Botet M
    J Immunol; 1996 Dec; 157(12):5367-74. PubMed ID: 8955184
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies.
    Galatiuc C; Gherman M; Metes D; Sulica A; DeLeo A; Whiteside TL; Herberman RB
    Cell Immunol; 1995 Jul; 163(2):167-77. PubMed ID: 7606790
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood.
    Miyawaki T; Uehara T; Nibu R; Tsuji T; Yachie A; Yonehara S; Taniguchi N
    J Immunol; 1992 Dec; 149(11):3753-8. PubMed ID: 1385530
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of a 33-kDa antigen Tm 1 on lymphocyte surface after modulation of cell surface antigens by IgM monoclonal antibody.
    Hara T; Jung LK; Fu SM
    J Immunol; 1988 Feb; 140(4):1028-33. PubMed ID: 2963858
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

  • 80. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
    Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
    J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.